Mitosol Powder For Topical Solution 0.2Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Mitosol: Powder for Topical solution (0.2mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

MITOMYCIN (mye toe MYE sin) is used during glaucoma surgery.

In-Depth Information

Mitosol Ophthalmic 0.2mg Powder for Topical Solution Kit

NDC: 497710002
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Glaucoma, Ocular Surgery

Storage Information
Protect from light
Store at controlled room temperature (between 68 and 77 degrees F)
Avoid excessive heat (above 104 degrees F)
Mitosol Ophthalmic 0.2mg Powder for Topical Solution Kit

Reported Side Effects for Mitosol Ophthalmic 0.2mg Powder for Topical Solution Kit

Bleeding Within The Eye Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Visual Impairment Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Wound Dehiscence Incidence:
1.0-10.0%*
Severity: SEVERE
Onset: DELAYED
Endophthalmitis Incidence:
>10.0%*
Severity: SEVERE
Onset: DELAYED
Low Eye Muscle Strength Incidence:
>10.0%*
Severity: MILD
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

SECOND Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

THIRD Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Mitosol

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5